clinical outcomes of radiation therapy for high-risk prostate cancer

被引：0
作者：
Gumenetskaya, Y. [1 ]
Makarova, K. [1 ]
Biryukov, V. [2 ]
机构：
[1] Hlth Minist Russian Federat, AF Tsyb Med Radiol Res Ctr, Fed State Budget Inst, Natl Med Res Ctr Radiol,Radiotherapy, Obninsk, Russia
[2] Hlth Minist Russian Federat, AF Tsyb Med Radiol Res Ctr, Fed State Budget Inst, Natl Med Res Ctr Radiol,Urol, Obninsk, Russia
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 158卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-0251
引用
收藏
页码：S208 / S208
页数：1
相关论文
共 50 条
[31]   IMPACT OF EXTENDED PELVIC LYMPH NODE DISSECTION ON THE CLINICAL OUTCOMES OF HIGH-RISK AND VERY HIGH-RISK PROSTATE CANCER [J].
Lee, Hyung Ho ;
Lim, Meng Shi ;
Yu, Ho Song ;
Bang, Woo Jin ;
Rha, Koon Ho ;
Hong, Sung Jun .
JOURNAL OF UROLOGY, 2012, 187 (04) :E314-E314
[32]   Identifying a Subgroup of High-Risk Prostate Cancer Patients With Worse Clinical Outcomes: Should There Be a "Very High-Risk" Group? [J].
Choi, S. ;
Levy, L. B. ;
Lee, K. K. ;
Nguyen, Q. N. ;
Lee, A. K. ;
McGuire, S. E. ;
Kudchadker, R. ;
Du, W. ;
Hoffman, K. E. ;
Mahmood, U. ;
Frank, S. J. ;
Kuban, D. A. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02) :E240-E241
[33]   Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy [J].
Cagney, Daniel N. ;
Dunne, Mary ;
O'Shea, Carmel ;
Finn, Marie ;
Noone, Emma ;
Sheehan, Martina ;
McDonagh, Lesley ;
O'Sullivan, Lydia ;
Thirion, Pierre ;
Armstrong, John .
BMC UROLOGY, 2017, 17
[34]   Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy [J].
Daniel N. Cagney ;
Mary Dunne ;
Carmel O’Shea ;
Marie Finn ;
Emma Noone ;
Martina Sheehan ;
Lesley McDonagh ;
Lydia O’Sullivan ;
Pierre Thirion ;
John Armstrong .
BMC Urology, 17
[35]   Survival after Radical Prostatectomy vs Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Letter [J].
Yu, Wenxiao ;
Guo, Jun .
JOURNAL OF UROLOGY, 2022, 207 (02) :478-479
[36]   Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Reply [J].
Chierigo, Francesco ;
Borghesi, Marco ;
Mantica, Guglielmo ;
Terrone, Carlo ;
Karakiewicz, Pierre I. .
JOURNAL OF UROLOGY, 2022, 208 (01) :224-224
[37]   Proton Therapy in the Management of High-Risk Prostate Cancer [J].
Bryant, C. M. ;
Henderson, R. H. ;
Hoppe, B. S. ;
Mendenhall, W. M. ;
Nichols, R. ;
Su, Z. ;
Li, Z. ;
Williams, C. R. ;
Morris, C. G. ;
Mendenhall, N. P. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 :S420-S420
[38]   AUO Neoadjuvant therapy for high-risk prostate cancer [J].
Rexer, H. ;
Bogemann, M. ;
Krafft, Ulrich .
UROLOGIE, 2024, 63 (11) :1211-1212
[39]   High-Risk Prostate Cancer: Local Therapy Matters [J].
Liss, Adam L. ;
Hamstra, Daniel A. .
AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (06) :14-19
[40]   Neoadjuvant therapy for high-risk localized prostate cancer [J].
Evan Y. Yu ;
William K. Oh .
Current Oncology Reports, 2003, 5 (3) :250-257
12345